The anaplastic lymphoma kinase (ALK) gene, that was discovered in 1994 in anaplastic large cell lymphoma (ALCL), encodes a transmembrane receptor tyrosine kinase [3], whose alteration leads to constitutive ALK activation and generates oncogenic activity [4], [5]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.